| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.9 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |